EGFR and non-small cell lung carcinoma: Several previous retrospective and clinical randomized controlled studies of patients with EGFR mutant NSCLC following EGFR TKIs therapy demonstrated that local therapy with surgery or radiation may lead to increased PFS [11, 12, 30].